about
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trialCirculating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective studyEffector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsAcute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis.Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interaction.Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.Questing for circadian dependence in ST-segment-elevation acute myocardial infarction: a multicentric and multiethnic study.High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.Proteome of platelets in patients with coronary artery disease.Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis.B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes*.Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome.Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps.Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty.Tissue Factor in Patients With Acute Coronary SyndromesPrognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromesIncidence and Relevance of Acute Kidney Injury in Patients Hospitalized With Acute Coronary SyndromesSerum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarctionRenal replacement therapy in patients with acute myocardial infarction: Rate of use, clinical predictors and relationship with in-hospital mortalityHigh-Sensitivity C-Reactive Protein and Acute Kidney Injury in Patients with Acute Myocardial Infarction: A Prospective Observational Study
P50
Q28257023-FBBD736D-D26E-4E8F-A918-0DCF8F1877BCQ34489684-5387E6A2-5413-4236-BBB7-6632B1082D23Q34542789-ED9F7E00-E061-4BCB-8902-75140D3F4BDBQ36151577-9E3487E0-8B28-4D3F-A1E5-2192F77257EFQ36366126-CA59D2B3-B52A-426E-B443-0EA8B5BD7CF6Q37240720-B3F7FC8B-5552-47EA-BF98-7462BFCF8880Q38884063-B102AA20-24B4-4B74-A755-5C8A54C4DF7AQ38918910-28CD69D5-D484-48AE-85D2-149BDA470DA1Q38939236-DD713754-1C69-4098-AFF7-75FD0404880CQ39421459-D75BFBF9-3BFB-409D-AF7B-0B6F5F0ECDCCQ40011125-FFD8F2A6-9EC1-4662-88FD-C85D384F68F2Q42170160-08E078B6-3DAE-449F-A2B4-AE969B35ECEDQ42781472-D0790C8A-A742-4005-A7D0-4BCDD90D0D32Q43130993-CB222D41-6486-4FE7-B93D-5E6DE31EE5A9Q43507476-9DDBEA82-E585-424B-8D99-EA126DE7CD02Q43610719-0E77036F-37FA-44A1-ADC5-4D98A765BC15Q44244598-0C7C18EF-C5DB-4BD4-BBC9-031CCFCFEB9CQ45868008-99F26B23-4EB8-4BB8-8D66-B5BF51CB0C9FQ46916784-6C1F5435-00E0-43DE-980B-5202916F779EQ54250182-19B7AE8E-423E-4CA2-8011-5A1BB8DC256BQ57398785-6E986E45-CC36-4A4C-A5FA-7055860535E0Q61387386-3E24528B-7BF8-4C59-AF6F-56A2ADC120F1Q61387394-459DDB6B-9103-42A7-A136-3F1658369C62Q83970061-5AD6B436-468C-43DE-BFF6-3F845793A9F5Q89430419-38662E7C-991D-4280-AA33-589788E49991Q92011895-25C1F77A-A1B0-4694-BD3F-E82F12EC23F1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Monica De Metrio
@ast
Monica De Metrio
@en
Monica De Metrio
@es
Monica De Metrio
@nl
type
label
Monica De Metrio
@ast
Monica De Metrio
@en
Monica De Metrio
@es
Monica De Metrio
@nl
prefLabel
Monica De Metrio
@ast
Monica De Metrio
@en
Monica De Metrio
@es
Monica De Metrio
@nl
P106
P1153
6504677516
P31
P496
0000-0002-1955-747X